Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation
NCT07101471
·
clinicaltrials.gov ↗
COMPLETED
Status
296
Enrollment
INDUSTRY
Sponsor class
Conditions
Alopecia Totalis/Universalis
Alopecia Areata(AA)
Interventions
DRUG:
Tofacitinib
Sponsor
NanoAlvand